Skip to main content
Clinical Trials/NCT01393977
NCT01393977UnknownPhase 2

Efficacy Difference Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Acute or Chronic Spinal Cord Injury in China

General Hospital of Chinese Armed Police Forces1 site in 1 country60 target enrollmentStarted: January 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Electromyogram and Electroneurophysiologic test

Study Overview

Brief Summary

The morbidity of spinal cord injury (SCI) is increasing significantly in China. The methods to treat SCI patients in sequela stage update are poor. Though traditional rehabilitation therapy is the routine method to treat SCI in sequela stage, its effect to improve the neurological disorders of these patients, such as the dysfunction of sense, motor, autologous adjustment of blood pressure control of urination and defecation, perspiration , etc. is unsatisfying. Rehabilitation Therapy can prevent the process of muscle atrophy and joint stiffness. However, it can not repair the damaged nerve function. Studies show that mesenchymal stem cell transplantation can remarkably improve the neurological function of SCI in animals without any severe side effect.

In this study, the investigators use mesenchymal stem cells derived from umbilical cord to treat 40 SCI patients (20 cases in early stage and 20 cases in sequela stage). The investigators also follow-up ten patients who only receive rehabilitation and another ten outpatients who accept neither stem cell therapy nor rehabilitation. On this basis, the investigators can compare the efficacy of these two treatments.

Detailed Description

Patients enrolled in this study need to finish our whole follow-up survey, which is carried out by clinical doctors and epidemiologist.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients or their curator must be able to give voluntary consent.
  • Patients or their curator Must be able to understand the information of study and in which group they are.
  • 20 years - 50 years of age can be enrolled.
  • Both male and female can be enrolled.
  • Patients have clear history of traumatic injury, and the spinal cord injury are confirmed by all of the examinations including MRI, electromyogram and electrophysiology.

Exclusion Criteria

  • Mental disorders
  • Women in pregnancy

Outcomes

Primary Outcomes

Electromyogram and Electroneurophysiologic test

Time Frame: 3 monthes after enrollment or transplantation

Brain stem auditory evoked potential (BAEP)and electromyography can display the nerve conduction velocity and the improvement of neurological function.

Secondary Outcomes

  • Electromyogram and Electroneurophysiologic test(12monthes after enrollment or transplantation)

Investigators

Sponsor
General Hospital of Chinese Armed Police Forces
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials